Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC April Update

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Budesonide (Pulmicort®) CFC-free has been accepted for use in the treatment of asthma based upon it replacing the equivalent CFC-containing metered dose inhalation device.

Brinzolomide eye drops (Azopt®) have been accepted for the treatment of elevated intraocular pressure in ocular hypertension and open-angle glaucoma.

Fluticasone furoate (Avamys®) nasal spray has been accepted for the treatment of the symptoms of allergic rhinitis in adults, adolescents (12 years and over) and children (6 to 11 years). The appraisal notes that other intranasal steroids are available at a lower cost.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC April Update' on Email Share 'SMC April Update' on Delicious Share 'SMC April Update' on Digg Share 'SMC April Update' on Facebook Share 'SMC April Update' on Google+ Share 'SMC April Update' on reddit Share 'SMC April Update' on StumbleUpon Share 'SMC April Update' on Twitter

atomic-wealth

No Comments to “SMC April Update”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,618 spam comments.

atomic-wealth
fond-illness
summer